View this student pharmacist session to learn from cell and gene therapy and managed care experts about their impact on healthcare, and other important aspects of these revolutionary medications!
On December 20, 2024, the Centers for Medicare & Medicaid Services (CMS) issued explanations for the maximum fair prices (MFPs) for the drugs selected for the IRA’s Medicare Drug Price Negotiation Program for the initial price applicability year (IPAY) 2026.
The Academy of Managed Care Pharmacy (AMCP) thanks the Department of Health and Human Services, the Department of Labor, and the Department of the Treasure (collectively, the Departments) for the opportunity to provide comments in response to the proposed rule titled “Enhancing Coverage of Preventive Services Under the Affordable Care Act [CMS 9887–P]” published in the Federal Register on October 28, 2024.
Pharmacy student Cayla Langley gained a unique behind-the-scenes look at managed care during the AMCP Partnership Forum on Closing the Gap in Real-World Evidence Use: A Collaborative Approach for Health Care Transformation.
On November 12, more than 50 managed care professionals and various health care stakeholders gathered in Old Town Alexandria, Virginia to examine these barriers to adoption for RWE in managed care.